BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21984115)

  • 1. Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
    Koshy M; Villano JL; Dolecek TA; Howard A; Mahmood U; Chmura SJ; Weichselbaum RR; McCarthy BJ
    J Neurooncol; 2012 Mar; 107(1):207-12. PubMed ID: 21984115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
    Zhu P; Du XL; Lu G; Zhu JJ
    Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Grossman SA; Ye X; Piantadosi S; Desideri S; Nabors LB; Rosenfeld M; Fisher J;
    Clin Cancer Res; 2010 Apr; 16(8):2443-9. PubMed ID: 20371685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma survival in the United States before and during the temozolomide era.
    Johnson DR; O'Neill BP
    J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
    Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
    Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
    Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
    Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
    Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.
    Darefsky AS; King JT; Dubrow R
    Cancer; 2012 Apr; 118(8):2163-72. PubMed ID: 21882183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Kozak KR; Moody JS
    Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategies for glioblastoma in older patients: age is just a number.
    Youssef M; Ludmir EB; Mandel JJ; Patel AJ; Jalali A; Treiber J; Wu J; McAleer MF; de Groot JF
    J Neurooncol; 2019 Nov; 145(2):357-364. PubMed ID: 31643011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide during radiotherapy of glioblastoma multiforme : Daily administration improves survival.
    Nachbichler SB; Schupp G; Ballhausen H; Niyazi M; Belka C
    Strahlenther Onkol; 2017 Nov; 193(11):890-896. PubMed ID: 28197654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival improvements with adjuvant therapy in patients with glioblastoma.
    Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF
    ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma patients' survival and its relevant risk factors during the pre-COVID-19 and post-COVID-19 pandemic: real-world cohort study in the USA and China.
    Qin L; Li H; Zheng D; Lin S; Ren X
    Int J Surg; 2024 May; 110(5):2939-2949. PubMed ID: 38376848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries.
    Efremov L; Abera SF; Bedir A; Vordermark D; Medenwald D
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3381-3390. PubMed ID: 33743072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
    Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
    Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.